Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Cardiac remodeling following reperfused acute myocardial infarction is linked to the concomitant evolution of vascular function as assessed by cardiovascular magnetic resonance.

Huttin O, Mandry D, Eschalier R, Zhang L, Micard E, Odille F, Beaumont M, Fay R, Felblinger J, Camenzind E, Zannad F, Girerd N, Marie PY.

J Cardiovasc Magn Reson. 2017 Jan 4;19(1):2. doi: 10.1186/s12968-016-0314-6.

2.

Acute myocardial infarction in the obstetric patient.

Firoz T, Magee LA.

Obstet Med. 2012 Jun;5(2):50-7. doi: 10.1258/om.2011.011080. Epub 2012 Mar 22. Review.

3.

Zofenopril Protects Against Myocardial Ischemia-Reperfusion Injury by Increasing Nitric Oxide and Hydrogen Sulfide Bioavailability.

Donnarumma E, Ali MJ, Rushing AM, Scarborough AL, Bradley JM, Organ CL, Islam KN, Polhemus DJ, Evangelista S, Cirino G, Jenkins JS, Patel RA, Lefer DJ, Goodchild TT.

J Am Heart Assoc. 2016 Jul 5;5(7). pii: e003531. doi: 10.1161/JAHA.116.003531.

4.

Effect of Beta Blockers and Renin-Angiotensin System Inhibitors on Survival in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.

Lee PH, Park GM, Kim YH, Yun SC, Chang M, Roh JH, Yoon SH, Ahn JM, Park DW, Kang SJ, Lee SW, Lee CW, Park SW, Park SJ.

Medicine (Baltimore). 2016 Mar;95(10):e2971. doi: 10.1097/MD.0000000000002971.

5.

Angiotensin II type 1 receptor blockers as a first choice in patients with acute myocardial infarction.

Lee JH, Bae MH, Yang DH, Park HS, Cho Y, Lee WK, Jeong MH, Kim YJ, Cho MC, Kim CJ, Chae SC; Korea Acute Myocardial Infarction Registry Investigators.

Korean J Intern Med. 2016 Mar;31(2):267-76. doi: 10.3904/kjim.2014.268. Epub 2015 Dec 23.

6.

Cardioprotective role of zofenopril in patients with acute myocardial infarction: a pooled individual data analysis of four randomised, double-blind, controlled, prospective studies.

Borghi C, Omboni S, Reggiardo G, Bacchelli S, Degli Esposti D, Ambrosioni E.

Open Heart. 2015 Sep 8;2(1):e000220. doi: 10.1136/openhrt-2014-000220. eCollection 2015.

7.

Randomised comparison of zofenopril and ramipril plus acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction: a post hoc analysis of the SMILE-4 Study in patients according to levels of left ventricular ejection fraction at entry.

Borghi C, Omboni S, Cicero AF, Bacchelli S, Degli Esposti D, Novo S, Vinereanu D, Ambrosio G, Ambrosioni E.

Open Heart. 2015 Aug 3;2(1):e000195. doi: 10.1136/openhrt-2014-000195. eCollection 2015.

8.

Impact of Angiotensin-converting enzyme inhibitors and Angiotensin receptor blockers on mortality of coronary artery bypass grafting.

Sharafi A, Davoodi S, Karimi AA, Ahmadi H, Abbasi K, Sheikh Fathollahi M, Bina P, Soleymanzadeh M, Fehri A, Davaran S, Jahangheeri S, Kassaian SE.

J Tehran Heart Cent. 2013 Oct 28;8(4):177-81.

9.

A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors.

Cressman AM, Macdonald EM, Fernandes KA, Gomes T, Paterson JM, Mamdani MM, Juurlink DN; Canadian Drug Safety Effectiveness Research Network (CDSERN).

Br J Clin Pharmacol. 2015 Oct;80(4):662-9. doi: 10.1111/bcp.12682. Epub 2015 Jul 2.

10.

High Incidence of ACE/PAI-1 in Association to a Spectrum of Other Polymorphic Cardiovascular Genes Involving PBMCs Proinflammatory Cytokines in Hypertensive Hypercholesterolemic Patients: Reversibility with a Combination of ACE Inhibitor and Statin.

AlBacha Jd, Khoury M, Mouawad C, Haddad K, Hamoui S, Azar A, Fajloun Z, Makdissy N.

PLoS One. 2015 May 14;10(5):e0127266. doi: 10.1371/journal.pone.0127266. eCollection 2015.

11.

Patterns of use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers among patients with acute myocardial infarction in China from 2001 to 2011: China PEACE-Retrospective AMI Study.

Liu J, Masoudi FA, Spertus JA, Wang Q, Murugiah K, Spatz ES, Li J, Li X, Ross JS, Krumholz HM, Jiang L; China PEACE Collaborative Group.

J Am Heart Assoc. 2015 Feb 23;4(2). pii: e001343. doi: 10.1161/JAHA.114.001343.

12.

Trends in the use of guideline-recommended medications and in-hospital mortality of patients with acute myocardial infarction in a Chinese population.

Hu J, Xie Y, Shu Z, Yang W, Zhan S.

PLoS One. 2015 Feb 23;10(2):e0118777. doi: 10.1371/journal.pone.0118777. eCollection 2015.

13.

Global perspective on acute coronary syndrome: a burden on the young and poor.

Vedanthan R, Seligman B, Fuster V.

Circ Res. 2014 Jun 6;114(12):1959-75. doi: 10.1161/CIRCRESAHA.114.302782. Erratum in: Circ Res. 2014 Aug 1;115(4):e8.

14.

Sex differences in the treatment and outcome of patients with acute coronary syndrome after percutaneous coronary intervention: a population-based study.

Lin CF, Shen LJ, Hsiao FY, Gau CS, Wu FL.

J Womens Health (Larchmt). 2014 Mar;23(3):238-45. doi: 10.1089/jwh.2013.4474. Epub 2013 Nov 28.

15.

Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4.

Borghi C, Ambrosioni E, Omboni S, Cicero AF, Bacchelli S, Esposti DD, Novo S, Vinereanu D, Ambrosio G, Reggiardo G, Zava D.

Clinicoecon Outcomes Res. 2013 Jul 8;5:317-25. doi: 10.2147/CEOR.S43138. Print 2013.

16.

Medication, reperfusion therapy and survival in a community-based setting of hospitalised myocardial infarction.

O'Brien EC, Rose KM, Suchindran CM, Stürmer T, Chang PP, Chambless L, Guild CS, Rosamond WD.

Heart. 2013 Jun;99(11):767-73. doi: 10.1136/heartjnl-2012-303244. Epub 2013 Mar 2.

17.

Explaining the increase in coronary heart disease mortality in Syria between 1996 and 2006.

Rastam S, Al Ali R, Maziak W, Mzayek F, Fouad FM, O'Flaherty M, Capewell S.

BMC Public Health. 2012 Sep 9;12:754. doi: 10.1186/1471-2458-12-754.

18.

ST Elevation Myocardial Infarction in the elderly.

Franken M, Nussbacher A, Liberman A, Wajngarten M.

J Geriatr Cardiol. 2012 Jun;9(2):108-14. doi: 10.3724/SP.J.1263.2011.12297.

19.

Angiotensin-converting enzyme inhibition and food restriction in diabetic mice do not correct the increased sensitivity for ischemia-reperfusion injury.

Van der Mieren G, Nevelsteen I, Vanderper A, Oosterlinck W, Flameng W, Herijgers P.

Cardiovasc Diabetol. 2012 Aug 1;11:89. doi: 10.1186/1475-2840-11-89.

20.

Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease.

Sabatine MS, Morrow DA, de Lemos JA, Omland T, Sloan S, Jarolim P, Solomon SD, Pfeffer MA, Braunwald E.

Circulation. 2012 Jan 17;125(2):233-40. doi: 10.1161/CIRCULATIONAHA.111.063842. Epub 2011 Dec 16.

Supplemental Content

Support Center